Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suman Kumar Ray

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Current Stem Cell Research & Therapy|February 10, 2021
Cancer Stem Cells: Current Status and Therapeutic Implications in Cancer Therapy-A New ParadigmSuman Kumar Ray, Sukhes Mukherjee
Current Pharmaceutical Biotechnology|December 14, 2020
Cell Free DNA as an Evolving Liquid Biopsy Biomarker for Initial Diagnosis and Therapeutic Nursing in Cancer- An Evolving Aspect in Medical BiotechnologySuman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|January 18, 2022
Challenges in Engendering Herd Immunity to SARS-CoV-2 Infection: Possibly Impossible But PlausibileSukhes Mukherjee, Suman Kumar Ray
Avicenna Journal of Medicine|December 9, 2021
COVID-19-Associated Mucormycosis, A New Incident in Recent Time: Is An Emerging Disease in The Near Future Impending?Suman Kumar Ray, Sukhes Mukherjee
Current Molecular Medicine|December 7, 2021
Epigenetic Reprogramming and Landscape of Transcriptomic Interactions: Impending Therapeutic Interference of Triple-Negative Breast Cancer in Molecular MedicineSuman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|September 1, 2022
A New Year, Newfangled COVID-19 Variant B.1.640.2 (IHU): What We Know So Far?Suman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|February 9, 2022
Third Wave of the COVID-19 Pandemic: Prominence of Initial Public Health InterferenceSukhes Mukherjee, Suman Kumar Ray
Critical Reviews in Immunology|April 6, 2021
Current Headway in Cancer Immunotherapy Emphasizing the Practice of Genetically Engineered T Cells to Target Selected Tumor AntigensSuman Kumar Ray, Sukhes Mukherjee
Current Molecular Medicine|April 2, 2021
Nutrigenomics and Lifestyle Facet- A Modulatory Molecular Evidence in Progression of Breast and Colon Cancer with Emerging ImportanceSuman Kumar Ray, Sukhes Mukherjee
Recent Patents on Biotechnology|November 14, 2023
Innovative Nanomaterials for Targeting Hypoxia to Improve Treatment for Triple-negative Breast CancerSuman Kumar Ray, Sukhes Mukherjee
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Current Stem Cell Research & Therapy|February 10, 2021
Cancer Stem Cells: Current Status and Therapeutic Implications in Cancer Therapy-A New ParadigmSuman Kumar Ray, Sukhes Mukherjee
Current Pharmaceutical Biotechnology|December 14, 2020
Cell Free DNA as an Evolving Liquid Biopsy Biomarker for Initial Diagnosis and Therapeutic Nursing in Cancer- An Evolving Aspect in Medical BiotechnologySuman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|January 18, 2022
Challenges in Engendering Herd Immunity to SARS-CoV-2 Infection: Possibly Impossible But PlausibileSukhes Mukherjee, Suman Kumar Ray
Avicenna Journal of Medicine|December 9, 2021
COVID-19-Associated Mucormycosis, A New Incident in Recent Time: Is An Emerging Disease in The Near Future Impending?Suman Kumar Ray, Sukhes Mukherjee
Current Molecular Medicine|December 7, 2021
Epigenetic Reprogramming and Landscape of Transcriptomic Interactions: Impending Therapeutic Interference of Triple-Negative Breast Cancer in Molecular MedicineSuman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|September 1, 2022
A New Year, Newfangled COVID-19 Variant B.1.640.2 (IHU): What We Know So Far?Suman Kumar Ray, Sukhes Mukherjee
Infectious Disorders Drug Targets|February 9, 2022
Third Wave of the COVID-19 Pandemic: Prominence of Initial Public Health InterferenceSukhes Mukherjee, Suman Kumar Ray
Critical Reviews in Immunology|April 6, 2021
Current Headway in Cancer Immunotherapy Emphasizing the Practice of Genetically Engineered T Cells to Target Selected Tumor AntigensSuman Kumar Ray, Sukhes Mukherjee
Current Molecular Medicine|April 2, 2021
Nutrigenomics and Lifestyle Facet- A Modulatory Molecular Evidence in Progression of Breast and Colon Cancer with Emerging ImportanceSuman Kumar Ray, Sukhes Mukherjee
Recent Patents on Biotechnology|November 14, 2023
Innovative Nanomaterials for Targeting Hypoxia to Improve Treatment for Triple-negative Breast CancerSuman Kumar Ray, Sukhes Mukherjee
Pageof 8